| Metric | FY2025 | FY2024 |
|---|---|---|
| Net sales | $462.1M+9.9% | $420.6M |
| Cost of sales | $201.8M+0.2% | $201.3M |
| Gross profit | $260.2M+18.7% | $219.2M |
| Selling, general and administrative expenses | $117.0M+26.2% | $92.7M |
| Income from operations | $143.3M+13.2% | $126.5M |
| Change in fair value of derivative liability - convertible notes redemption make-whole provision | $425K | — |
| Interest income | $5.5M+19.5% | $4.6M |
| Interest expense | -$13.2M+34.6% | -$20.2M |
| Amortization of deferred financing costs | -$629K+43.0% | -$1.1M |
| Loss on extinguishment of debt | -$148K | — |
| Total other expense, net | -$8.4M+49.1% | -$16.4M |
| Income (loss) before income taxes | $134.9M+22.5% | $110.1M |
| Income tax (expense) | -$885K-3787.5% | $24K |
| Net income (loss) | $134.0M+21.7% | $110.1M |
| Net income (loss) attributable to non-controlling interest | $139.9M+24.4% | $112.5M |
| Net income (loss) attributable to common stockholders | -$5.9M-153.8% | -$2.3M |
| Net income (loss) per share attributable to common stockholders - basic | -$690.00-155.6% | -$270.00 |
| Net income (loss) per share attributable to common stockholders - diluted | -$690.00-155.6% | -$270.00 |
| Weighted average shares used to compute net income (loss) per share attributable to common stockholders - basic | $8523124000.00-0.0% | $8525998000.00 |
| Weighted average shares used to compute net income (loss) per share attributable to common stockholders - diluted | $8523124000.00-0.0% | $8525998000.00 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.